Gastrointestinal Cancers Symposium

The latest news from ASCO GI, including researcher interviews and physician perspective.

Meeting News

Rectal, left-sided colon cancers show 'a continuum' of molecular variances

January 26, 2017
Rectal and left-sided colon cancers are not clearly delineated by location but rather are characterized by a range of distinct molecular variations…
Meeting News

Racial, ethnic disparities identified in young gastric cancer patients

January 25, 2017
Various racial and ethnic disparities affect disease presentation, treatment delivery and outcomes among young patients with gastric cancer…
Meeting News

Aspirin linked to increased GI bleeding risk, reduced CRC risk

January 24, 2017
Long-term use of aspirin was associated with a reduced risk for colorectal cancer, but an increased risk for gastrointestinal bleeding, highlighting…
Meeting News

PET scans could offer alternative route for treatment of esophageal cancer

January 18, 2017
PET scans used to assess tumor response to initial chemotherapy allowed clinicians to tailor additional treatments for patients with esophageal…
Meeting News

Watch-and-wait approach may be alternative to surgery for certain patients with rectal cancer

January 18, 2017
Patients with rectal cancer who achieve a clinical complete response to treatment may be able to follow a watch-and-wait approach rather than undergo…
Meeting News

Moderate exercise may prolong OS in patients with metastatic colorectal cancer

January 17, 2017
Patients with metastatic colorectal cancer who engaged in moderate exercise for at least 30 minutes a day experienced reduced risks for cancer…
Meeting News CoverageVideo

VIDEO: Novel prediction model accurately determines survival in gastric cancer

February 5, 2016
SAN FRANCISCO — Daniel V.T. Catenacci, MD, a GI medical oncologist at the University of Chicago, discusses a novel gastric cancer prognostic…
Meeting News Coverage

Guest Commentary: Update on use of irreversible electroporation for locally advanced pancreatic cancer

February 3, 2016
In this guest commentary, Marcovalerio Melis, MD, FACS, discusses irreversible electroporation for locally advanced pancreatic cancer, following a
Meeting News CoveragePerspective

PD-1 blockade promising in MMR deficient GI cancers

February 3, 2016
SAN FRANCISCO — Programmed death-1 blockade demonstrated promising activity in mismatch repair deficient gastrointestinal cancers in a phase 2…
Meeting News CoveragePerspective

Ziv-aflibercept does not improve FOLFOX efficacy in gastric, GE junction cancer

February 2, 2016
SAN FRANCISCO — Adding ziv-aflibercept to FOLFOX regimens did not significantly improve survival among patients with chemotherapy-naïve…